Ranjith Ramasamy | |
---|---|
Nationality | American |
Alma mater |
|
Known for |
|
Awards |
|
Scientific career | |
Fields |
|
Institutions |
Ranjith Ramasamy is a consultant urologist at Jumeirah American Clinic in Dubai, UAE, [3] [4] and the former Director of the Reproductive Urology Fellowship program at the University of Miami's Miller School of Medicine. [5] [6] [7]
An American medical researcher and urologist, Ramasamy is known for academic contributions to reproductive medicine, including testosterone deficiency, regenerative therapy, erectile dysfunction, and prostate cancer studies. [8] [1] Ramasamy has co-authored a significant number of publications in the domain of male infertility and sexual dysfunction. [9] [10] Ramasamy is a recipient of the American Society for Reproductive Medicine Award. [11]
Ramasamy graduated with a B.S degree in Cell Biology and Neuroscience from Rutgers University in 2003. He continued to study at Rutgers, receiving his medical degree there in 2007. Ramasamy completed his urology residency training at Weill Cornell Medicine and NewYork-Presbyterian Hospital in 2013. He did his medical research on a fellowship, sponsored by the National Institutes of Health, in Male Reproductive Medicine and Microsurgery at Baylor College of Medicine in 2015. [12] [13]
Since 2005, Ramasamy has contributed to medical research and publications in medical journals on the subject of Leydig stem cells, Testosterone Deficiency, Regenerative therapy, erectile dysfunction, prostate cancer, among others. [8] His main research areas of interests are in male infertility and sexual dysfunction. [10] [9] [14]
In 2020-21, Ramasamy contributed to research of coronavirus impact on male fertility and sexually transmitted diseases. [15] [16] [17] [18]
Ramasamy has been instrumental in creating a urology app intended to prepare medical students and trainees for urology board examinations. [19] He also serves as a reviewer for medical professional journals, including European Urology , Fertility and Sterility , The Journal of Urology , BJU International , Urology , the Indian Journal of Urology , and others [14]
Ramasamy has been among the first urology specialists to research and discover the impact of Covid-19 on male infertility and erectile dysfunction. His work, along with other researchers, has been published in The World Journal of Men's Health, [20] contributed to understanding of the COVID-19 infection and its relation to causing the underlying endothelial dysfunction, a condition in which the small blood vessels fail to perform normally and damage male erectile system. [21] [22] [16] [17]
Ramasamy is also a recipient of the 2019 George Paff Teaching Award of Excellence for teaching urology to Miller School of Medicine students. [23]
Ramasamy also found and validated that males who have recovered from SARS-CoV-2 acute phase are unlikely to be a source for sexual transmissions of SARS-CoV-2. Further investigation into sperm parameters before and after the COVID-19 mRNA vaccine was published in JAMA Network in 2022. [24] [25]
In September 2021, based on the previous work "Phase II Randomized, Clinical Trial Evaluating 2 Schedules of Low-Intensity Shockwave Therapy for the Treatment of Erectile Dysfunction", [26] Ramasamy became a principal researcher for the “Combined Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction” study that is funded by a three-year grant provided by the National Institutes of Health. [27]
In 2023, Ramasamy received the Gold Cystoscope Award for creative impactful work in andrology, mentorship, clinical scholarship and research. [2] [28]
Erectile dysfunction (ED), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity. It is the most common sexual problem in males and can cause psychological distress due to its impact on self-image and sexual relationships.
Andrology is a name for the medical specialty that deals with male health, particularly relating to the problems of the male reproductive system and urological problems that are unique to men. It is the parallel to gynecology, which deals with medical issues which are specific to female health, especially reproductive and urologic health.
Epididymal hypertension (EH), informally referred to as blue balls for males or blue vulva for females, is a harmless but uncomfortable sensation in the genital regions during a prolonged state of sexual arousal. It usually resolves within hours unless relieved through an orgasm.
Hypogonadism means diminished functional activity of the gonads—the testicles or the ovaries—that may result in diminished production of sex hormones. Low androgen levels are referred to as hypoandrogenism and low estrogen as hypoestrogenism. These are responsible for the observed signs and symptoms in both males and females.
Testicular atrophy is a medical condition in which one or both testicles diminish in size and may be accompanied by reduced testicular function. Testicular atrophy is not related to the temporary shrinkage of the surrounding scrotum, which might occur in response to cold temperature.
Sexual medicine or psychosexual medicine as defined by Masters and Johnsons in their classic Textbook of Sexual Medicine, is "that branch of medicine that focuses on the evaluation and treatment of sexual disorders, which have a high prevalence rate." Examples of disorders treated with sexual medicine are erectile dysfunction, hypogonadism, and prostate cancer. Sexual medicine often uses a multidisciplinary approach involving physicians, mental health professionals, social workers, and sex therapists. Sexual medicine physicians often approach treatment with medicine and surgery, while sex therapists often focus on behavioral treatments.
Azoospermia is the medical condition of a man whose semen contains no sperm. It is associated with male infertility, but many forms are amenable to medical treatment. In humans, azoospermia affects about 1% of the male population and may be seen in up to 20% of male infertility situations in Canada.
Male infertility refers to a sexually mature male's inability to impregnate a fertile female. In humans, it accounts for 40–50% of infertility. It affects approximately 7% of all men. Male infertility is commonly due to deficiencies in the semen, and semen quality is used as a surrogate measure of male fecundity. More recently, advance sperm analyses that examine intracellular sperm components are being developed.
Testicular sperm extraction (TESE) is a surgical procedure in which a small portion of tissue is removed from the testicle and any viable sperm cells from that tissue are extracted for use in further procedures, most commonly intracytoplasmic sperm injection (ICSI) as part of in vitro fertilisation (IVF). TESE is often recommended to patients who cannot produce sperm by ejaculation due to azoospermia.
Reproductive medicine is a branch of medicine concerning the male and female reproductive systems. It encompasses a variety of reproductive conditions, their prevention and assessment, as well as their subsequent treatment and prognosis.
Sudhakar Krishnamurti, is a medical doctor, clinical andrologist, microsurgeon, and sexual medicine expert. He is director of the Andromeda Andrology Center, Hyderabad, India.
Fertility preservation is the effort to help cancer patients retain their fertility, or ability to procreate. Research into how cancer, ageing and other health conditions effect reproductive health and preservation options are growing. Specifically sparked in part by the increase in the survival rate of cancer patients.
FNA mapping is an application of fine-needle aspiration (FNA) to the testis for the diagnosis of male infertility. FNA cytology has been used to examine pathological human tissue from various organs for over 100 years. As an alternative to open testicular biopsy for the last 40 years, FNA mapping has helped to characterize states of human male infertility due to defective spermatogenesis. Although recognized as a reliable, and informative technique, testis FNA has not been widely used in U.S. to evaluate male infertility. Recently, however, testicular FNA has gained popularity as both a diagnostic and therapeutic tool for the management of clinical male infertility for several reasons:
Dr. Paul J Turek is an American physician and surgeon, men's reproductive health specialist, and businessman. Turek is a recent recipient of a National Institutes of Health (NIH) grant for research designed to help infertile men become fathers using stem cells.
Ashok Agarwal is the Director of the Andrology Center, and also the Director of Research at the American Center for Reproductive Medicine at Cleveland Clinic, Cleveland, USA. He is Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, USA. Ashok is a Senior Staff in the Cleveland Clinic's Glickman Urological and Kidney Institute. He has published extensive translational research in human infertility and assisted reproduction.
Ronald Virag is a French cardiovascular surgeon who specialises in andrology, the study of the male reproductive system. After training in general and cardiovascular surgery at Paris University, he shifted his focus to the study of erectile dysfunction, which has been his primary area of study since 1978. In 1981, he founded a private institute in France dedicated to the clinical study of erectile dysfunction and developed early programs using intracavernosal drugs to treat the condition.
Raymond A. Costabile is Professor, and Chair Urology with the Department of Urology at the School of Medicine of the University of Virginia. Costabile is a retired Colonel in the US Army and the former Chief of Urology Service at Madigan Army Medical Center. Costabile is an author; his articles on men's reproductive health and infertility have been published in the Journal of Urology and Proceedings in the National Academy of Sciences, among other peer-reviewed scholarly journals. He has also been featured in television interviews in the national media.
Marc Goldstein is an American urologist who is the Matthew P. Hardy Distinguished Professor of Reproductive Medicine, and Urology at Weill Cornell Medical College; Surgeon-in-Chief, Male Reproductive Medicine and Surgery; and Director of the Center of Male Reproductive Medicine and Microsurgery at New York Presbyterian Hospital. He is Adjunct Senior Scientist with the Population Council's Center for Biomedical Research, located on the campus of Rockefeller University.
Sandro La Vignera is a Full Professor of endocrinology, faculty of medicine at the University of Catania. He works at the University Hospital “Policlinico G. Rodolico” of Catania at the Operative Unit of Endocrinology. From 2017 present in the Top World Scientist ranking published by Plos Biology.
Larry I. Lipshultz is an American urologist, surgeon, researcher, and teacher. He currently serves as Professor of Urology, Lester and Sue Smith Endowed Chair in Reproductive Medicine, and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine, Houston, Texas.